Onderneming Myovant Sciences Ltd.
Aandelen
MYOV
BMG637AM1024
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 579
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04-01-21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27-12-19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27-12-19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04-01-21 |
Director/Board Member | 59 | 22-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 97 235 316 | 46 097 791 ( 47,41 %) | 0 | 47,41 % |
Bedrijfsgegevens
Myovant Sciences Ltd.
11-12 St. James?s Square Suite 1, 3rd Floor
SW1Y 4LB, London
+
http://www.myovant.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |